Ironwood Pharmaceuticals | IRWD - Interest Expense On Debt


Ironwood Pharmaceuticals reported $8.74M in Interest Expense on Debt for its fiscal quarter ending in December of 2024.





Interest Expense On Debt Change Date
Acadia Pharmaceuticals USD 0 4.12M Sep/2024
Agios Pharmaceuticals USD 1.39B 85.53M Sep/2025
Alnylam Pharmaceuticals USD 44.4M 4.15M Sep/2025
Amarin USD 3K 5K Dec/2024
Ardelyx USD 5.8M 784K Sep/2025
Astellas Pharma JPY 3.91B 320M Mar/2025
AstraZeneca USD 303M 38M Jun/2025
Charles River Laboratories USD 25.4M 4.56M Sep/2025
Exact Sciences USD 9.79M 46K Sep/2025
Halozyme Therapeutics USD 4.3M 98K Sep/2025
Incyte USD 592K 2K Sep/2025
Ironwood Pharmaceuticals USD 8.74M 506K Dec/2024
MacroGenics USD 3.34M 2.54M Sep/2025
Moderna USD 12.14B 12.13B Sep/2025
Myriad Genetics USD 800K 100K Mar/2025
Pacira USD 4.28M 456K Sep/2025
PTC Therapeutics USD 2.64B 2.61B Sep/2025
Sarepta Therapeutics USD 7.56M 2.33M Sep/2025
Takeda JPY 123.63B 40.49B Dec/2025
Ultragenyx Pharmaceutical USD 14.15M 108K Sep/2025